High Quality Pharmaceutical Chemical for Antimalaria Amodiaquine Tablet
Model No.: DAWAGSH549
It is bioactivated hepatically to its primary metabolite, N-desethylamodiaquine, by the cytochrome p450 enzyme CYP2C8. Among amodiaquine users, several rare but serious side effects have been reported and linked to variants in the CYP2C8 alleles. CYP2C8*1 is characterized as the wild-type allele, which shows an acceptable safety profile, while CYP2C8*2, *3 and *4 all show a range of "poor metabolizer" phenotypes. People who are poor metabolizers of amodiaquine display lower treatment efficacy against malaria, as well as increased toxicity. Several studies have been conducted to determine the prevalence of CYP2C8 alleles amongst malaria patients in East Africa, and have tentatively shown the variant alleles have significant prevalence in that population. About 3.6% of the population studied showed high risk for a poor reaction to or reduced treatment outcomes when treated with amodiaquine. This information is useful in developing programs of pharmacovigilance in East Africa, and have important clinical considerations for prescribing antimalarial medications in regions with high CYP2C8 variant frequency.
If you want to order,please directly Contact us:
We are lookinh for the agent and distributors all over the world.
Welcome for your join!!!
Contact us if you need more details on Pharmaceutical. We are ready to answer your questions on packaging, logistics, certification or any other aspects about High Quality、Chemical. If these products fail to match your need, please contact us and we would like to provide relevant information.
Product Categories : Antimalaria Drugs